VCNX Insider Trading

Insider Ownership Percentage: 51.30%
Insider Buying (Last 12 Months): $3,004,638.14
Insider Selling (Last 12 Months): $2,257.92

Vaccinex Insider Trading History Chart

This chart shows the insider buying and selling history at Vaccinex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vaccinex Share Price & Price History

Current Price: $6.10
Price Change: Price Decrease of -0.7 (-10.29%)
As of 04/12/2024 01:00 AM ET

This chart shows the closing price history over time for VCNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vaccinex Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2023Strydonck Gerald E. VanDirectorSell224$10.08$2,257.92View SEC Filing Icon  
10/3/2023Albert FriedbergDirectorBuy214,285$14.00$2,999,990.00339,128View SEC Filing Icon  
10/3/2023Maurice ZaudererCEOBuy357$13.02$4,648.141,222View SEC Filing Icon  
2/23/2022Strydonck Gerald E VanDirectorBuy95$277.20$26,334.00View SEC Filing Icon  
1/27/2022Jacob B. FriebergDirectorBuy429$233.10$99,999.90View SEC Filing Icon  
1/27/2022Maurice ZaudererCEOBuy8,580$233.10$1,999,998.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vaccinex (NASDAQ:VCNX)

50.11% of Vaccinex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VCNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vaccinex Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2024AIGH Capital Management LLC817,061$0.54M0.2%-25.1%6.542%Search for SEC Filing on Google Icon
2/9/2024Worth Venture Partners LLC654,079$0.44M0.2%-8.8%5.237%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.48,221$54K0.0%-93.4%0.386%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC717,559$0.81M0.5%+417.0%16.308%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC680,000$0.77M0.0%N/A15.455%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC1,090,173$1.23M0.6%-19.4%24.777%Search for SEC Filing on Google Icon
5/16/2023Susquehanna International Group LLP99,105$40K0.0%+250.2%0.181%Search for SEC Filing on Google Icon
5/15/2023AIGH Capital Management LLC951,801$0.38M0.1%-61.2%1.735%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC103,898$42K0.0%N/A0.189%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC2,451,801$1.66M0.5%+17.8%4.915%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC37,964$25K0.0%-46.4%0.076%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC100,268$50K0.0%+92.1%0.235%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC151,666$0.16M0.0%+391.2%0.355%Search for SEC Filing on Google Icon
5/17/2022Worth Venture Partners LLC66,856$88K0.0%N/A0.157%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.727,265$0.96M0.0%+16.7%1.705%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC2,081,801$2.63M0.6%N/A4.880%Search for SEC Filing on Google Icon
11/16/2021Telemetry Investments L.L.C.132,500$0.29M0.4%+10.4%0.430%Search for SEC Filing on Google Icon
11/15/2021Natixis31,895$69K0.0%N/A0.104%Search for SEC Filing on Google Icon
11/12/2021Oppenheimer & Co. Inc.31,751$69K0.0%-24.3%0.103%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC38,026$0.11M0.0%+103.9%0.123%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.395,522$1.11M0.0%N/A1.390%Search for SEC Filing on Google Icon
8/16/2021Telemetry Investments L.L.C.120,000$0.34M0.5%+14.3%0.422%Search for SEC Filing on Google Icon
8/16/2021State Street Corp67,200$0.19M0.0%N/A0.236%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC104,114$0.29M0.0%+59.4%0.366%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.600,624$1.68M0.0%+145.9%2.111%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC18,652$56K0.0%N/A0.066%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.20,447$61K0.0%-41.9%0.072%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp17,954$54K0.0%N/A0.063%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC65,331$0.19M0.0%N/A0.230%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG28,708$86K0.0%N/A0.101%Search for SEC Filing on Google Icon
5/10/2021Oppenheimer & Co. Inc.42,951$0.13M0.0%-24.3%0.151%Search for SEC Filing on Google Icon
5/4/2021Institute for Wealth Management LLC.20,000$60K0.0%N/A0.070%Search for SEC Filing on Google Icon
2/17/2021Tacita Capital Inc13,574$28K0.0%N/A0.061%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC40,583$84K0.0%N/A0.181%Search for SEC Filing on Google Icon
2/11/2021Oppenheimer & Co. Inc.56,751$0.12M0.0%+141.1%0.254%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC26,249$47K0.0%N/A0.117%Search for SEC Filing on Google Icon
10/20/2020Wedbush Securities Inc.31,000$55K0.0%N/A0.154%Search for SEC Filing on Google Icon
5/18/2020MSD Partners L.P.1,161,855$4.65M1.3%-5.2%7.102%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vaccinex logo
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. It has also developed ActivMAb, an antibody drug discovery platform based on a novel method for complex targets, such as multi-pass membrane receptors or large and diverse libraries of full-length human monoclonal antibodies on the surface of pox viruses. The company was incorporated in 2001 and is headquartered in Rochester, New York.
Read More on Vaccinex

Today's Range

Now: $6.10
Low: $5.87
High: $6.90

50 Day Range

MA: $8.32
Low: $6.13
High: $12.25

52 Week Range

Now: $6.10
Low: $5.87
High: $100.80

Volume

11,507 shs

Average Volume

8,961 shs

Market Capitalization

$7.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of Vaccinex?

Vaccinex's top insider investors include:
  1. Albert Friedberg (Director)
  2. Maurice Zauderer (CEO)
  3. Strydonck Gerald E Van (Director)
Learn More about top insider investors at Vaccinex.